Fenwick & West advised DexCare on the deal.DexCare, a data-driven intelligence company focused on healthcare access, announced its $50 million Series B financing. The round was led…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
